Biomeditsina va amaliyot jurnali, 2022 №2
Subject of the article
EPIDEMIOLOGICAL ANALYSIS OF THE INCIDENCE OF ESOPHAGUS CANCER IN THE ANDIJAN, NAMANGAN, AND FERGANA REGIONS OF THE REPUBLIC OF UZBEKISTAN (208-213)
Authors
MAMARASULOVA Dilfuzahon Zakirjanovna ZULUNOV Azizbek Tohirovich ABDULLAXONOVA Gulhayoxon Bahodirjon kizi
Institution
Andijan State Medical Institute
Abstract
ANNOTATION A study of the Fergana Valley showed that by the end of 2020, the registration of cancer patients was 26,405 people with malignant neoplasms. The highest prevalence of malignant neoplasms was in the Namangan region (0.32%), in Andijan (0.21%), and in the Fergana region (0.28%). Among all patients with esophageal cancer registered with the OOD by the end of 2020, 63% were rural residents, although rural residents account for 48-49% of the population. This difference may be explained by the presence of risk factors such as nutritional deficiency and low socioeconomic status.
Key words
Keywords: esophageal cancer, prevalence, epidemiology
Literature
1. Abemayor E, Moore DM, Hanson DG: Identification of synchronous esophageal tumors in patients with head and neck cancer. J Surg Oncol 38 (2): 94-6, 1988. [PubMed] 2. Ajani J.A., Barthel J.S., Bentrem D.J., D’Amico T.A., Das P., Denlinger C.S., Fuchs C.S., Gerdes H., Glasgow R.E., Hayman J.A., et al. Esophageal and Esophagogastric Junction Cancers. J. Natl. Compr. Cancer Netw. 2011;9:830–887. doi: 10.6004/jnccn.2011.0072. [PubMed] [CrossRef] [Google Scholar] 3. Cheng K.K., Sharp L., McKinney P., Logan R.F., Chilvers C.E.D., Cook-Mozaffari P., Ahmed A., Day N. A case-control study of oesophageal adenocarcinoma in women: A preventable disease. Br. J. Cancer. 2000;83:127–132. doi: 10.1054/bjoc.2000.1121. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 4. Engel LS, Chow WH, Vaughan TL, et al.: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95 (18): 1404-13, 2003. [PubMed] 5. Isolauri J, Markkula H: Lye ingestion and carcinoma of the esophagus. Acta Chir Scand 155 1. Abemayor E, Moore DM, Hanson DG: Identification of synchronous esophageal tumors in patients with head and neck cancer. J Surg Oncol 38 (2): 94-6, 1988. [PubMed] 2. Ajani J.A., Barthel J.S., Bentrem D.J., D’Amico T.A., Das P., Denlinger C.S., Fuchs C.S., Gerdes H., Glasgow R.E., Hayman J.A., et al. Esophageal and Esophagogastric Junction Cancers. J. Natl. Compr. Cancer Netw. 2011;9:830–887. doi: 10.6004/jnccn.2011.0072. [PubMed] [CrossRef] [Google Scholar] 3. Cheng K.K., Sharp L., McKinney P., Logan R.F., Chilvers C.E.D., Cook-Mozaffari P., Ahmed A., Day N. A case-control study of oesophageal adenocarcinoma in women: A preventable disease. Br. J. Cancer. 2000;83:127–132. doi: 10.1054/bjoc.2000.1121. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 4. Engel LS, Chow WH, Vaughan TL, et al.: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95 (18): 1404-13, 2003. [PubMed] 5. Isolauri J, Markkula H: Lye ingestion and carcinoma of the esophagus. Acta Chir Scand 155